These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A pharmacological classification of drugs of abuse. Nahas GG Bull Narc; 1981; 33(2):1-19. PubMed ID: 6272921 [TBL] [Abstract][Full Text] [Related]
7. The pharmacology of mood-altering drugs of abuse. Carr LA Prim Care; 1993 Mar; 20(1):19-31. PubMed ID: 8464940 [TBL] [Abstract][Full Text] [Related]
8. Screening of dependence liability of drugs using rats. Hosoya E Pharmacol Ther B; 1979; 5(1-3):515-7. PubMed ID: 573907 [No Abstract] [Full Text] [Related]
9. Dependence on psychotropic drugs: an overview. Edwards JG; Cantopher T; Olivieri S Postgrad Med J; 1984; 60 Suppl 2():29-40. PubMed ID: 6463009 [No Abstract] [Full Text] [Related]
10. Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects. Cubała WJ; Landowski J; Wichowicz HM Br J Clin Pharmacol; 2008 Mar; 65(3):444-5. PubMed ID: 17875189 [No Abstract] [Full Text] [Related]
11. The integration of pharmacotherapy and nonpharmacotherapy. Miller NS; Smith DE J Addict Dis; 1997; 16(4):51-64. PubMed ID: 9328809 [No Abstract] [Full Text] [Related]
12. Novel psychoactive substances and behavioral addictions. Martinotti G; Corazza O; Achab S; Demetrovics Z Biomed Res Int; 2014; 2014():534523. PubMed ID: 25610866 [No Abstract] [Full Text] [Related]
13. Phenomenology and theoretical basis of tolerance and dependence. Martin WR NIDA Res Monogr; 1984; 54():12-26. PubMed ID: 6442758 [No Abstract] [Full Text] [Related]
14. Proposed changes in DSM-III substance use disorders: description and rationale. Rounsaville BJ; Spitzer RL; Williams JB Am J Psychiatry; 1986 Apr; 143(4):463-8. PubMed ID: 3953889 [TBL] [Abstract][Full Text] [Related]
15. Peregrinations among drugs of dependence: Nathan B. Eddy Memorial Award lecture. Hollister LE NIDA Res Monogr; 1989; 95():36-43. PubMed ID: 2640995 [No Abstract] [Full Text] [Related]
16. Neurological complications of substance abuse. Brust JC Res Publ Assoc Res Nerv Ment Dis; 1992; 70():193-203. PubMed ID: 1535931 [No Abstract] [Full Text] [Related]
17. [When drug withdrawal for safety concerns may be harmful. A case report with tetrabamate]. Raveloarimisy L; Gras-Champel V; Lemaire-Nanni E; Burde-Hamm F; Andréjak M; Guilbaud JC Therapie; 2002; 57(6):593-5. PubMed ID: 12666269 [No Abstract] [Full Text] [Related]
18. Treatment-induced stress syndromes. Healy D Med Hypotheses; 2010 May; 74(5):764-8. PubMed ID: 20171790 [TBL] [Abstract][Full Text] [Related]
19. Molecular and cell biology of addiction. Hyman SE Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):609-13. PubMed ID: 8400475 [TBL] [Abstract][Full Text] [Related]
20. Addiction to an experience: a social-psychological-pharmacological theory of addiction. Peele S NIDA Res Monogr; 1980 Mar; 30():142-6. PubMed ID: 6779171 [No Abstract] [Full Text] [Related] [Next] [New Search]